<SEC-DOCUMENT>0000105770-20-000002.txt : 20200116
<SEC-HEADER>0000105770-20-000002.hdr.sgml : 20200116
<ACCEPTANCE-DATETIME>20200116171558
ACCESSION NUMBER:		0000105770-20-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200110
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200116
DATE AS OF CHANGE:		20200116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		20531739

	BUSINESS ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		530 HERMAN O. WEST DRIVE
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8kexxonsupplyagree.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:ff3a3b0f45254663bd230cd8e92ee553,x:cb5c2760f9564a46aa8d181ec774f2d9-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:wst="http://www.westpharma.com/20200110" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1Jan10" name="dei:AmendmentFlag" id="Fact-99E0C554F1F4A1249AA1A9F26E2E3C80-wk-Fact-99E0C554F1F4A1249AA1A9F26E2E3C80" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1Jan10" name="dei:EntityCentralIndexKey" id="Fact-9944FE10589927B82154A9F26E2D8B7D-wk-Fact-9944FE10589927B82154A9F26E2D8B7D">0000105770</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="wst-20200110.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1Jan10">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000105770</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-10</xbrli:startDate>
			<xbrli:endDate>2020-01-10</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="s48E6162A7135356B5456A9F26DFF398C"></a></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d120335582e123-wk-Fact-9E73DC91627A594FBD18A9F26E118803" name="dei:DocumentType" contextRef="D2020Q1Jan10"><span style="font-size:12pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:12pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of earliest event reported) &#8211; </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d120335582e141-wk-Fact-D1DD157B6FF0615670DDA9F26E103813" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1Jan10" format="ixt:datemonthdayyearen">January 10, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;"><img src="form8k01102020.jpg" alt="form8k01102020.jpg" style="height:88px;width:218px;"></img></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e160-wk-Fact-2BF25DBCE68F72608DB5A9F26E2AAD3B" name="dei:EntityRegistrantName" contextRef="D2020Q1Jan10">WEST PHARMACEUTICAL SERVICES, INC.</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:682px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:166px;"></td><td style="width:48px;"></td><td style="width:29px;"></td><td style="width:16px;"></td><td style="width:197px;"></td><td style="width:16px;"></td><td style="width:209px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e219-wk-Fact-5DDDF12B45FB99C128E8A9F26E183B91" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1Jan10" format="ixt-sec:stateprovnameen">Pennsylvania</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e239-wk-Fact-8221ECE2757BED81FB8AA9F26E183346" name="dei:EntityFileNumber" contextRef="D2020Q1Jan10">1-8036</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e249-wk-Fact-AD37F401C67F3F58AE7EA9F26E18AFA5" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1Jan10">23-1210010</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</span></div><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">of incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Commission File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(IRS Employer</span></div><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification No.)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e333-wk-Fact-978DD8B8F59FBF9F1373A9F26E17539D" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1Jan10">530 Herman O. West Drive,</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e338-wk-Fact-CA2F25F701CCAF99E91EA9F26E17BBE8" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1Jan10">Exton,</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e343-wk-Fact-2717BAC9949AC136843CA9F26E18D639" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1Jan10">PA</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e363-wk-Fact-3D2E1FEFE9033C2D9CF2A9F26E179B6F" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1Jan10">19341-0645</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;Registrant&#8217;s telephone number, including area code: </span><span><ix:nonNumeric id="d120335582e404-wk-Fact-97E0CCF5AEA88F39FCB4A9F26E1010A4" name="dei:CityAreaCode" contextRef="D2020Q1Jan10"><span style="font-weight:bold;">610</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;">-</span><span><ix:nonNumeric id="d120335582e409-wk-Fact-E4DA183C2C5BCF984036A9F26E10231D" name="dei:LocalPhoneNumber" contextRef="D2020Q1Jan10"><span style="font-weight:bold;">594-2900</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Not Applicable</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former name or address, if changed since last report.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="line-height:120%;padding-bottom:8px;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d120335582e450-wk-Fact-6940C6DEE86FD13BBD7DA9F26E213009" name="dei:WrittenCommunications" contextRef="D2020Q1Jan10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d120335582e469-wk-Fact-E127CAD935C6134B91EAA9F26E235EA3" name="dei:SolicitingMaterial" contextRef="D2020Q1Jan10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d120335582e488-wk-Fact-EC5A2F5001C5CC10EA70A9F26E1E4E1F" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1Jan10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><span><ix:nonNumeric id="d120335582e507-wk-Fact-1CBC94AA3A127D9E2BA8A9F26E1522FD" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1Jan10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.74396135265701%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:40%;"></td><td style="width:19%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Trading Symbol</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e546-wk-Fact-221C0AE6CCFF5D8C2BC7A9F26E2730CF" name="dei:Security12bTitle" contextRef="D2020Q1Jan10">Common Stock, par value $0.25 per share</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e551-wk-Fact-5992DD38E1EE4DE0F8A1A9F26E2606E8" name="dei:TradingSymbol" contextRef="D2020Q1Jan10">WST</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d120335582e556-wk-Fact-C676FF440C68D3B32718A9F26E264370" name="dei:SecurityExchangeName" contextRef="D2020Q1Jan10" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Emerging growth company </span><span><ix:nonNumeric id="d120335582e564-wk-Fact-FDFC846D40A2FB096049A9F26E10B048" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1Jan10" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.93719806763285%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">1</span></div></div><hr style="page-break-after:always"></hr><div><a id="s567409C14DA4C00A0E92A9F26FE30FAC"></a></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.01. Entry into a Material Definitive Agreement.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 10, 2020, West Pharmaceutical Services, Inc. (the &#8220;Company&#8221;) entered into a global master supply agreement (the &#8220;Agreement&#8221;) with ExxonMobil Chemical Company (&#8220;EMCC&#8221;). The Agreement is effective for the period January 1, 2019 through December 31, 2023.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under the Agreement, EMCC and certain of its subsidiaries have agreed to supply certain identified Exxon</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></span><span style="font-family:inherit;font-size:10pt;"> (Exxon is a registered trademark of ExxonMobil Corporation) butyl polymers to the Company and certain of its subsidiaries and affiliates. The EMCC products are used as a principal raw material in a broad range of the Company&#8217;s polymer-based pharmaceutical packaging products. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The summary of the terms is qualified in its entirety by reference to the Agreement, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01&#160;Financial Statements and Exhibits.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:9%;"></td><td style="width:12%;"></td><td style="width:79%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(d)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;10.1+</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Global Master Supply Agreement, entered into on January 10, 2020, and effective from January 1, 2019 through December 31, 2023, between West Pharmaceutical Services, Inc. and ExxonMobil Chemical Company.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;104</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cover page from the Company&#8217;s Current Report on Form 8-K, dated January 10, 2020, formatted in Inline XBRL.</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">+ Portions of this exhibit (indicated therein by asterisks) have been omitted for confidential treatment.</span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2</span></div></div><hr style="page-break-after:always"></hr><div><a id="s53804B2B5F3883594336A9F270035914"></a></div><div><div style="line-height:144%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:46%;"></td><td style="width:54%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ George L. Miller</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">George L. Miller</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Senior Vice President, General Counsel and Corporate Secretary</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">January 16, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">3</span></div></div><hr style="page-break-after:always"></hr><div><a id="s5A5B606BBD2A2A22B80CA9F270358750"></a></div><div><div style="line-height:144%;text-align:left;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</span></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">10.1+</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exh101exxonsupplyagree.htm"><span style="font-family:inherit;font-size:10pt;">Global Master Supply Agreement, entered into on January 10, 2020, and effective from January 1, 2019 through December 31, 2023, between West Pharmaceutical Services, Inc. and ExxonMobil Chemical Company.</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The cover page from the Company&#8217;s Current Report on Form 8-K, dated January 10, 2020, formatted in Inline XBRL.</span></div><div style="padding-bottom:2px;text-align:left;padding-left:4px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">4</span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exh101exxonsupplyagree.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA1B535C7F37E52F20581A9F26EE7A366"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit 10.1</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">[*****] Text omitted for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:13pt;"><font style="font-family:inherit;font-size:13pt;font-style:italic;font-weight:bold;">GLOBAL MASTER SUPPLY AGREEMENT</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:14px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Global Master Supply Agreement ("Agreement" or "Contract") is  between ExxonMobil Chemical Company, a division of Exxon Mobil Corporation ("Seller"),on behalf of itself and in the interest of  the ExxonMobil affiliates listed on Attachment B (each an "ExxonMobil Selling Affiliate" or "EMCC/A" or collectively, "ExxonMobil Selling Affiliates"), and West Pharmaceutical Services, Inc. ("Buyer"), on behalf of itself and the Buyer affiliates listed on Attachment C (each a "Buyer Affiliate" or &#8220;West/A" or collectively, "Buyer  Affiliates").</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">PRODUCTS, QUANTITY, PRICE</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the provisions of this Agreement, ExxonMobil Selling Affiliates agree to sell to Buyer Affiliates, and Buyer Affiliates agree to purchase from ExxonMobil Selling Affiliates, the following product(s) (collectively, "Product"):</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.36585365853658%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:13%;"></td><td style="width:12%;"></td><td style="width:9%;"></td><td style="width:9%;"></td><td style="width:9%;"></td><td style="width:9%;"></td><td style="width:9%;"></td><td style="width:30%;"></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Products</font></div></td><td colspan="6" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Quantity [Metric Tons / Year]</font></div></td><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Container</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Package</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maximum</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased metal crates</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased metal crates</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td colspan="6" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">not defined</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased metal crates</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to this Agreement's terms and conditions, Buyer Affiliates shall purchase and ExxonMobil Selling Affiliates shall sell the yearly minimum amount of Product amounts (in the aggregate) listed above. Buyer or Buyer Affiliates may request to purchase amounts over the Product maximum amounts per year, however, it shall be solely within Seller or any ExxonMobil Selling Affiliate&#8217;s discretion whether and under which conditions to accommodate Buyer's request.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer Affiliates shall issue a purchase order(s), or call off order(s) when purchasing Product from ExxonMobil Selling Affiliates in writing pursuant to this Contract ("Purchase Order"). Such Purchase Order(s) shall specify (a) the quantity of Product, and (b) general date of delivery. All Purchase Orders agreed to be filled by an ExxonMobil Selling affiliate shall be deemed to be a separate agreement between the relevant ExxonMobil Selling Affiliate and the relevant Buyer Affiliate, incorporating the terms of this Contract. Notwithstanding anything to the contrary in the attachments ExxonMobil and the ExxonMobil Selling Affiliates shall not unreasonably reject any Purchase Order that otherwise complies with the terms of this Agreement. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Order(s), order acknowledgements and similar form documents evidencing the purchase or sale of Products, including any terms and conditions contained or referenced therein, shall not supersede, add to or amend in any way this Contract. In the event of any conflict between the terms of this Contract and the terms of any Purchase Order, order acknowledgement or similar document the terms of this Contract shall prevail.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">PRICING</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For calendar years 2019, 2020, 2021, 2022 and 2023, the price of Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates will comprise the Base Price, the crude adjustment and the freight cost depending on Incoterms.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Base price</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Requested delivery date</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1.2019 - 28.2.2019: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3.2019 - 31.12.2019:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1.2020 - 31.12.2020:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1.2021 - 31.12.2021:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1.2022 - 31.12.2022:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1.2023 - 31.12.2023:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All [*****] grades except [*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]: [*****] $/t</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Base prices listed above are non-delivered pricing (i.e., Ex-Works designated Exxon Affiliate location (see Attachment B) - Incoterms 2010 (&#8220;EXW&#8221;) and does not include freight or insurance.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller and Buyer shall meet on or before December 31, [*****] to assess the requirements for a price and/or volume adjustment in good faith on the price for Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates for years [*****] and [*****]. </font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding anything to the contrary in Attachments A, G and H to this Agreement, the parties agree that any permitted adjustments to the price, freight or payment terms for Products sold hereunder will be governed by the terms of the Pricing and Payment Terms sections of this Agreement. </font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer Affiliates shall pay ExxonMobil's Selling Affiliates invoice(s) not later than the days set forth in Attachment E hereto. All invoices shall be paid in full by wire transfer in accordance with the invoice's instructions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Crude Trigger Clause </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product price(s) shall be subject to the Average Brent crude oil price evolution (as further detailed below) in order to reflect the cost of energy. Should the Average Brent crude oil price at any moment during the term of this Agreement move to a different Average Brent crude oil price bracket as mentioned below, Seller may increase or decrease the Product price by $[*****] for every $[*****] change in the Average Brent crude oil price. In no event shall the Product price&#8217;s increase or decrease exceed $[*****] for every $[*****] change in the Average Brent crude oil price brackets. Each Average Brent crude oil bracket is calculated on a $5 range basis (e.g., $30-$35, $40-$45, $50-$55, etc.). </font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Average Brent crude oil price evolution shall be expressed as the three-month average spot price per barrel of the Brent crude </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">oil (as published in the Wall Street Journal). This average shall be calculated as the average of the prices for the immediate preceding three consecutive calendar months, with each month's price calculated as the average of the daily prices. </font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any conversion between United States Dollars and Euros will be carried out by using the average of the European Central Bank&#8217;s daily foreign exchange rate as published in Reuter's screen ECB 37 for the period in question.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any Product price adjustment shall take effect the month immediately following Seller&#8217;s notification of an increase or decrease in Product price.</font></div><div style="line-height:120%;text-align:justify;padding-left:8px;text-indent:-2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">TITLE AND RISK OF LOSS - EXXONMOBIL CHEMICAL COMPANY AND EXXONMOBIL CHEMICAL SERVICES AMERICAS INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title to the Product(s) to be sold and delivered hereunder will transfer simultaneously with the risks upon delivery as per the applicable lncoterm (lncoterms 2010) in Attachment E with the exception of the following:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For Product sold and/or sourced by ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. that is shipped overseas to a non-U.S. location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. to Buyer Affiliates at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For Product sold by ExxonMobil Chemical Company that is transported by land to Mexico, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company to Buyer Affiliates at the frontier between Laredo, Texas, U.S.A. and Mexico (not unloaded), but prior to the customs border of Mexico.  </font></div><div style="line-height:120%;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">LOCATIONS OF SUPPLY</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer/Buyer Affiliates that may purchase Product from ExxonMobil Selling Affiliates are listed in Attachment C. Other products and locations may be added upon mutual agreement in writing.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any and all sales of Product between ExxonMobil Chemical Company and/or ExxonMobil Chemical Services Americas, Inc.  and Buyer Affiliates in the U.S., Mexico and Brazil shall be subject to the terms and conditions set forth in Attachment A hereto.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any and all sales of Product between ExxonMobil Petroleum &amp; Chemical and Buyer Affiliates in France, Germany, Denmark, Serbia, Ireland and the United Kingdom shall be subject to the terms and conditions set forth in Attachment H hereto.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any and all sales of Product between ExxonMobil Chemical Asia Pacific and Buyer Affiliates in Singapore, China and India shall be subject to the terms and conditions set forth in Attachment G hereto.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer/Buyer Affiliates are responsible for the Product and returnable crates in their custody at the sales value of the Product and the replacement value of the metal crates, respectively. The terms relating to the use and return of metal crates are set out in Attachment F.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">AFFILIATES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ExxonMobil Selling Affiliates participating in this Agreement are listed in Attachment B. Buyer Affiliates participating in this Agreement are listed in Attachment C. Seller and Buyer each represent and warrant that each will cause its respective affiliates, so listed, to become bound to the terms of this Agreement.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">QUALITY</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product shall conform to ExxonMobil Selling Affiliates' standard sales specifications as of the date of shipment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sellers agrees to support the creation of purchasing specifications for Products by Buyer and agrees to supply Products in accordance to those purchasing specifications. Seller has the right to review each purchasing specification and needs to accept in writing before such purchasing specifications become effective. Seller has the right to take exceptions to terms and provisions in these purchasing specifications if in contradiction with Seller&#8217;s Sales specifications, General Terms and Condition of Sales or other Seller&#8217;s procedures and policies.</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer and Seller agree to enter into negotiations on an extended Quality Assurance Agreement. Provided that these negotiations will be successful, such agreement shall then be incorporated into this Contract as an amendment to it. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">AGREEMENT PERIOD</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective Date: January 1, 2019</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Termination Date: December 31, 2023</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">PAYMENT TERMS</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer/Buyer Affiliates shall pay for Product by Electronic Funds Transfer (EFT) through the Automated Clearing House (ACH) using the Corporate Trade Exchange (CTX) format, according to the payment terms described in Attachment E.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">TECHNICAL SUPPORT</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EMCC/A will provide technical expertise in the use of Products and will use its technical centers to enhance technical communications with West Pharmaceutical Services Affiliates technical centers. West/A will share its needs with EMCC/A and how they relate to West/A activities to help guide ExxonMobil Chemical Affiliates technical efforts.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parties have created and continue to entertain a research and development governance structure with a steering team, program management team and working team. The charter, roles and meeting frequencies are described in mutually agreed documents and will be reviewed periodically as deemed appropriate by the parties. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">SAFETY, HEALTH &amp; ENVIRONMENT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Safety, health and environment (SHE) professional representatives from both parties shall endeavor to meet once a year (face to face or via teleconference) to exchange and benchmark on best practices. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parties agree to notify each other on SHE related issues that may arise from the use of Products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parties agree to explore the reuse/recycling of articles, manufacturing trim and scrap Buyer produces from Products purchased from Seller.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">AUDIT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On request of Buyer, Buyer is allowed to carry out on-site manufacturing and quality audits in manufacturing units where Products are produced. The frequency of such audits shall not exceed one audit per site within three years</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">SUPPLY SECURITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer is seeking for an increased level of supply security and additional risk mitigation strategies and actions in case of short and long term supply disruptions of Products.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller agrees to enter into discussions and negotiations with Buyer and to take reasonable efforts to enhance such risk mitigation and business continuity strategies. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">COLLABORATION PLANNING AND SUPPLY ASSURANCE, FORECAST</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer and Seller agree to convene once every calendar year to discuss annual Product quantities. Buyer has provided Seller with an annual non-binding forecast for the respective contract year. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As requested by the Seller, the Buyer will provide a quarterly forecast for the subsequent contract years. Seller will provide Buyer a quarterly overview of the planned production run of each Butyl grade purchased for Buyer.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller shall acknowledge in writing the requested delivery and timing of Products and Volumes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CHANGE CONTROL</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes to the manufacturing process are carefully controlled and are subject to review and formal approval by EMCC/A or other affiliates of Exxon Mobil Corporation prior to implementation. Buyer will be informed at least six months in advance of any change determined by EMCC/A to result in a significant change to the chemical composition or performance of the Product.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CREDIT</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If Seller/ExxonMobil Selling Affiliates' has reasonable grounds for insecurity with respect to the financial responsibility of Buyer/Buyer Affiliates, Seller/ExxonMobil Selling Affiliates may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller/ExxonMobil Selling Affiliates shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer/Buyer Affiliates shall pay all costs of collection, including attorneys' fees, in addition to all other amounts due.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">SET-OFF AND RECOVERY</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates. For purposes hereof, any and all written agreements between Buyer and Seller shall be deemed to be part of an integrated agreement set forth herein.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">ECONOMIC CONDITIONS AND TRENDS CLAUSE</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is understood and agreed that the basis for this Agreement is an extraordinary level of mutual trust and confidence between the parties, not only in matters of price, quality, and service relating to the quantities of Product purchased and sold hereunder, but also with respect to the accommodation of changes that may develop in the business environment or the pursuit of such mutual undertakings as may benefit either or both of the parties to this Agreement. Moreover, the terms relating to quantity and price presume the continuation of economic conditions and trends now prevailing, including but not limited to levels of industrial production, tire demand, labor rates, energy costs, and foreign exchange relationships. In the event that, in the view of either party, a significant change of any kind does occur which materially and significantly alters the value received by either party in this transaction, that party may, upon written notice of its election and reasons therefor, request that this Agreement be renegotiated and the other party will be obligated to enter into the renegotiation unless the request is formally withdrawn. Neither party shall unreasonably request such renegotiation </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">FAILURE IN PERFORMANCE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding anything to the contrary in Attachments A, G or H, no liability shall result to either party from delay in performance or non-performance of an obligation hereunder (including an obligation to make payment)  in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to, acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks,</font><font style="font-family:inherit;font-size:10pt;">&#32;shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision. Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if, supplies of Product </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">or distribution logistics for</font><font style="font-family:inherit;font-size:10pt;">, or feedstock for making Product, from any of Seller's/ExxonMobil Selling Affiliates&#8217; existing sources are curtailed or are inadequate to meet Seller's/ExxonMobil Selling Affiliates' own requirements and/or its obligations to its customers, Seller&#8217;s/ExxonMobil Selling Affiliates' obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's/ExxonMobil Selling Affiliates&#8217; reasonable judgment, to apportion fairly among Seller's/ExxonMobil Selling Affiliates&#8217; own requirements and its customers such Product as received and as may be available in the ordinary and usual course of Seller's/ExxonMobil Selling Affiliates' business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller/ExxonMobil Selling </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Affiliates shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CHANGE IN CIRCUMSTANCES</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding anything to the contrary in Attachments A, G or H, in connection with any Change in Circumstances (as defined below), and without limiting Seller's/ExxonMobil Selling Affiliate's other rights under this Agreement or applicable law, Seller/ExxonMobil Selling  Affiliates shall have the right: (i) only if required to enable Seller/ExxonMobil Selling Affiliate to comply with applicable laws and regulations, to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable (ii) to modify the payment terms hereunder; and/or (iii) to require that Buyer/Buyer Affiliates pay in advance for shipments hereunder.  </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer/Buyer Affiliates shall notify Seller/ExxonMobil Selling Affiliates, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation. If Seller/ExxonMobil Selling Affiliates elects to exercise any of its rights under the preceding paragraph, Seller/ExxonMobil Selling Affiliates shall so notify Buyer/Buyer Affiliates, in writing, within forty-five (45) days after receipt of Buyer's/Buyer Affiliates' notice.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As used above, &#8220;Change in Circumstances&#8221; means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest in Buyer/Buyer Affiliates (or of at least twenty-five percent (25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer/Buyer Affiliates (&#8220;Buyer&#8217;s Parent&#8221;)) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer&#8217;s /Buyer Affiliates&#8217; (or Buyer&#8217;s Parent&#8217;s) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer&#8217;s/Buyer Affiliates (or Buyer&#8217;s Parent&#8217;s) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">WARRANTY DISPUTE RESOLUTION</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding anything to the contrary in Attachments A, G or H</font><font style="font-family:inherit;font-size:11pt;">, </font><font style="font-family:inherit;font-size:10pt;">if Buyer/Buyer Affiliates and Seller/ExxonMobil Selling Affiliates are unable to agree on the quality or quantity of Product delivered and received following their internal investigations and good faith efforts to resolve the dispute, the parties shall cooperate to have the Products in dispute analyzed by a mutually selected independent testing laboratory.  The results of such laboratory testing shall be final and binding on the parties on the issue of conformance of the Products.  If the Products are determined to be conforming, then Buyer/Buyer Affiliates shall bear the cost of such laboratory testing.  If the Products are determined not to be conforming, then Seller/ExxonMobil Selling Affiliates shall bear the cost of such laboratory testing.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">US LAW AND REGULATION</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Parties represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti-money laundering laws, rules, and regulations of any government, including the U.S. Foreign Corrupt Practices Act, and the applicable country legislation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions as such laws and regulations may be amended or updated from time to time.</font></div><div style="line-height:120%;text-align:justify;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">DATA PRIVACY</font></div><div style="line-height:120%;text-align:justify;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller informs Buyer that any information relating to an identified or identifiable natural person (&#8220;individual&#8221;), in particular business contact details of Buyer&#8217;s personnel and contractors, which is communicated by or on behalf of Buyer to Seller (&#8220;personal data&#8221;), will be subject to data processing by Seller. To learn more about the processing of personal data and about individual&#8217;s rights in relation to the processing, read the Seller data privacy notice at http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the Seller data privacy notice.</font></div><div style="line-height:120%;text-align:justify;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">USE ACKNOWLEDGEMENT</font></div><div style="line-height:120%;text-align:justify;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with Section 8 of Attachment A, the &#8220;Warranties&#8221; section of Attachment G and Section 14 of Attachment H, Seller hereby expressly acknowledges that Buyer has provided notice so Seller that Product(s) purchased hereunder will be used by Buyer in connection with only the following medical applications:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Elastomeric components for pharmaceutical packaging and containment solutions, including stoppers, seals, plungers, and syringe components.</font></div></td></tr></table><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">TERMINATION</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notwithstanding anything to the contrary in Attachments A, G or H, neither party can suspend its further performance, terminate this Agreement or require specific performance of the other party of this Agreement in whole or in part as a result of the other party&#8217;s material breach of the terms and conditions of this Agreement without first providing notice to such party in writing and thirty (30) days&#8217; opportunity to cure the material breach (and then only if such party fails to cure such breach). </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">TERMS AND CONDITIONS</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following attachments are made part of this Agreement:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment A - &#160;&#160;&#160;&#160;ExxonMobil Chemical Company and ExxonMobil Chemical Services Americas Inc. </font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General Terms and Conditions of Sale </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment B - &#160;&#160;&#160;&#160;List of ExxonMobil Affiliates/Divisions </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment C - &#160;&#160;&#160;&#160;List of West Pharmaceutical Services Affiliates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment D - &#160;&#160;&#160;&#160;Notices</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment E - &#160;&#160;&#160;&#160;Payment Terms </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment F - &#160;&#160;&#160;&#160;Returnable Metal Crates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment G - &#160;&#160;&#160;&#160;ExxonMobil Chemical Asia Pacific - Terms and Conditions of Sale</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment H - &#160;&#160;&#160;&#160;ExxonMobil Chemical Petroleum &amp; Chemical BVBA - Terms and Conditions of Sale</font></div><div style="line-height:120%;text-align:justify;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">GOVERNING LAW</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Agreement shall be governed and construed in accordance with the law set forth in the ExxonMobil Selling Affiliate's general terms and conditions, as applicable.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">BINDING EFFECT</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller shall not be obligated by this Agreement unless Buyer executes and returns this Agreement to Seller no later than thirty (30) days from the date Seller signs below.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">ENTIRE AGREEMENT</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Agreement and its attachments constitute the complete and exclusive statement of the terms of agreement between Seller and Buyer and supersede any and all agreements, representations and understandings, oral and written made prior to signing and relating to the subject matter of this Agreement. In no event shall either party be responsible for any special, punitive, or consequential damages whatsoever. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None of the parties shall be legally bound by anything contained in this instrument, or any negotiations pursuant thereto, unless and until the companies have agreed to all terms and this instrument has been signed by authorized representatives of each company.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">ORDER OF PRECEDENCE</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event of conflict between this Agreement (including the Failure in Performance and Change in Circumstances clauses herein) and the Attachments hereto, this Agreement shall prevail, except with respect to the governing law specified in Attachments A, G and H, respectively, and as applicable to the appropriate ExxonMobil Selling Affiliate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.51219512195122%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:45%;"></td><td style="width:10%;"></td><td style="width:45%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BUYER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SELLER</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACCEPTED AND AGREED TO BY BUYER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ExxonMobil Chemical Company, a division of</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DATE OF:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exxon Mobil Corporation</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 10, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: December 11, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Eric M. Green</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kurt Aerts</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">BY: Eric M. Green</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">BY: Kurt Aerts</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: President and CEO</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: Vice President, SERI</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT A</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Master Supply Agreement</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ExxonMobil Chemical Company (EMCC) &amp;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ExxonMobil Chemical Services Americas Inc. (EMCSA)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Standard Terms and Conditions of Sales and Acceptance of Order</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1. PRICE AND QUANTITY; PRICE ADJUSTMENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Except as otherwise provided  in this Agreement, and without regard to any course of dealing between the parties: (1) Seller shall not be obligated to sell or deliver any quantity of product(s) covered hereby ("Product") beyond the amount, if any, which in Seller's sole judgment, is available for such purpose as of the proposed date of shipment to Buyer; (2) the price of Product shall be Seller's price therefor as of the date of shipment; (3) Seller reserves the right to set minimums and/or premiums or to reject orders for unusual configurations, sizes and folds; (4) an overrun or underrun of up to ten percent (10%) shall constitute due performance of any order; (5) any freight allowances shall be those specified by Seller as of the date of shipment; and (6) Buyer shall allow Seller a reasonable period for delivery of shipments of Product. Seller may change any price, freight or payment term hereof upon no less than thirty (30) days' prior written notice; provided, however, that Seller may at any time institute or remove a temporary voluntary allowance of other similar competitive allowance without prior notice.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2. PAYMENT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless otherwise specified in Attachment E of the Agreement, Payment for Product shall be made in U.S. Dollars and shall be due, in good funds in Seller's account, no later than thirty (30) days after the date of shipment. With respect to any monetary obligations of Buyer or Buyer's affiliates owed to Seller, Seller may (i) set-off such obligations against any sums owing to Buyer or Buyer's affiliates; and/or (ii) recoup such obligation from any amounts paid to Buyer or Buyer's affiliates by Seller.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3. TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any tax (except income taxes), excise or other governmental charge that now or in the future may be imposed, increased or levied upon the production, value added, sale, transportation, storage, handling, delivery, use or disposal of Product sold hereunder which Seller may be required to pay, shall be paid by Buyer to Seller in addition to the purchase price. Buyer shall provide Seller, on request, with properly completed exemption certificates for any tax from which Buyer claims exemption.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4. CREDIT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If Seller has reasonable grounds for insecurity with respect to the financial responsibility of Buyer, Seller may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer shall pay all costs of collection, including attorneys' fees, in addition to other amounts due.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5. SET-OFF AND RECOVERY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates.  For purposes hereof, any and all agreements between Buyer and Seller, whether written or oral, shall be deemed to be part of an integrated agreement set forth herein.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6. CHANGE IN CIRCUMSTANCES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with any Change in Circumstances (as defined below), and without limiting Seller&#8217;s other rights under this Agreement or applicable law, Seller shall have the right: (i) to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable; (ii) to modify the payment terms hereunder; and/or (iii) to require Buyer to pay in advance for shipments hereunder.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer shall notify Seller, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation.  If Seller elects to exercise any of its rights under the preceding paragraph, Seller shall so notify Buyer, in writing, within forty-five (45) days after receipt of Buyer&#8217;s notice.  As used above, &#8220;Change in Circumstances&#8221; means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">in Buyer (or of at least twenty-five percent 25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer (&#8220;Buyer&#8217;s Parent&#8221;) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer&#8217;s (or Buyer&#8217;s Parent&#8217;s) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer&#8217;s (or Buyer&#8217;s Parent&#8217;s) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7. TITLE; RISK OF LOSS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title to Product and risk of loss shall pass to Buyer at Seller's facilities upon delivery to a carrier or into Buyer's transport unless otherwise specified in the agreement.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8. LIMITED WARRANTY AND MEDICAL APPLICATIONS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE PRODUCT DESCRIPTION HEREIN, AND SELLER MAKES NO WARRANTY, EXPRESS OR IMPLIED, OF FITNESS FOR PARTICULAR USE, MERCHANTABILITY OR OTHERWISE WITH RESPECT TO PRODUCT, WHETHER USED SINGLY OR IN COMBINATION WITH OTHER SUBSTANCES OR IN ANY PROCESS, EXCEPT THAT PRODUCT SOLD HEREUNDER SHALL CONFORM TO SELLER'S STANDARD SALES SPECIFICATIONS AS OF THE DATE OF SHIPMENT. Without limiting the foregoing, Seller does not recommend nor endorse the use of Product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise, with respect to Product(s)&#8217; use in any medical application.  Buyer represents and warrants that no Product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without Seller&#8217;s prior express written acknowledgement.  Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of Product(s) purchased hereunder in any medical application.  </font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9. INSPECTION AND LIMITATION OF LIABILITY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer shall inspect and test Product delivered hereunder for damage, defect or shortage immediately upon receipt at Buyer's plant or such other location as determined by Buyer and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt. Any claims for shortages must be supported by certified railroad scale tickets (or similar documents if shipments were not by rail) and Seller shall have an opportunity to have an independent weighing. All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives written notice of such claim not later than one hundred fifty (150) days after Buyer's receipt of Product as to which such claim is made.  Defective or nonconforming Product shall be replaced by Seller without additional charge, or in lieu thereof, at Seller's option, Seller may refund the purchase price upon return of such Product at Seller's expense and such refund or replacement shall constitute Buyer&#8217;s sole and exclusive remedy.  NOTWITHSTANDING THE ABOVE AND REGARDLESS OF THE CIRCUMSTANCES, SELLER'S TOTAL LIABILITY TO BUYER FOR ANY AND ALL CLAIMS, LOSSES OR DAMAGES ARISING OUT OF ANY CAUSE WHATSOEVER, WHETHER BASED IN CONTRACT, NEGLIGENCE OR OTHER TORT, STRICT LIABILITY, BREACH OF WARRANTY OR OTHERWISE, SHALL IN NO EVENT EXCEED THE PURCHASE PRICE OF PRODUCT IN RESPECT TO WHICH SUCH CAUSE AROSE. IN NO EVENT SHALL SELLER BE LIABLE FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES. Any cause of action that Buyer may have against Seller and which may arise in connection with the transaction(s) specified herein must be commenced within two (2) years after the cause of action has accrued.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10. SAFETY, HEALTH AND INDEMNITY</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller shall furnish to Buyer Material Safety Data Sheets, including warnings and safety and health information concerning Products and/or the containers therefor. Buyer agrees to disseminate such information so as to give warning of possible hazards to persons who Buyer can reasonably foresee may be exposed to such hazards, including but not limited to Buyer's employees, agents, contractors or customers.  Buyer shall instruct its employees, agents, contractors and customers on the safe handling, use, selling, storing, transportation and disposal practices for the Product. IF BUYER FAILS TO DISSEMINATE SUCH WARNINGS AND INFORMATION, BUYER AGREES TO DEFEND AND INDEMNIFY SELLER AGAINST ANY AND ALL LIABILITY ARISING OUT OF OR IN ANY WAY CONNECTED WITH SUCH FAILURE, INCLUDING BUT NOT LIMITED TO LIABILITY FOR INJURY, SICKNESS, DEATH AND PROPERTY DAMAGE; PROVIDED, HOWEVER, THAT IF SELLER IN THIS INSTANCE HAS CONTRIBUTED TO SUCH LIABILITY, BUYER'S INDEMNITY TO SELLER SHALL BE REDUCED BY THE PROPORTION IN WHICH SELLER CONTRIBUTED TO SUCH LIABILITY. Seller will provide Buyer with reasonable notice and opportunity to defend in the event any claim or demand is made on Seller as to which such indemnity relates.</font></div><div style="line-height:120%;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11. CARS, TRUCKS AND BARGES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer shall unload railroad cars, trucks and barges furnished by Seller within the free time specified by tariffs or time periods on file with applicable regulatory bodies, or promptly after receipt if no such tariffs or time periods are on file, and pay any charges </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">resulting from its failure to do so directly to the common carrier upon receipt of invoice therefor. Buyer shall pay Seller's daily charges for trip-leased tank cars for tank cars held longer than seven (7) days from constructive placement. BUYER ASSUMES FULL RESPONSIBILITY FOR USE AND CONDITION OF CARS, TRUCKS AND BARGES WHILE IN BUYER'S POSSESSION AND AGREES TO (1) COMPENSATE SELLER FOR LOSS OR DAMAGE TO SELLER'S PROPERTY AND (2) INDEMNIFY AND SAVE SELLER HARMLESS FROM ANY LOSS OR DAMAGE TO PROPERTY OTHER THAN SELLER'S AND FROM ANY INJURIES TO PERSONS RELATING IN ANY WAY TO THE USE OF SUCH CAR(S), TRUCK(S) AND BARGE(S) WHILE SUCH ARE IN BUYER'S POSSESSION. Buyer shall report to Seller promptly any damage that may be sustained by the car(s), truck(s) or barge(s) in Buyer's possession.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12. LEASED TRACKS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller may elect to provide rail cars of Product to Buyer on leased tracks. If Seller does so, Buyer shall contact Seller to receive shipments of Product from the leased tracks and not request such shipment directly from the railroad.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13. FAILURE IN PERFORMANCE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No liability shall result to either party from delay in performance or non-performance in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks, shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision.  Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of or distribution logistics for Product, or feedstock for making Product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirements and/or its obligations to its customers, Seller's obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not) such Product as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph.  </font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14. INTENTIONALLY OMITTED</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15. EXPORT COMPLIANCE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transaction(s) specified herein, unless otherwise indicated, constitute domestic sales within the United States.  For domestic U.S. sales, where Buyer chooses to subsequently export the Product, Buyer shall comply with all applicable laws relating to export controls and economic sanctions, including, but not limited to, those maintained by the US Department of the Treasury (Office of Foreign Assets Controls) and the US Department of Commerce (Bureau of Industry and Security). For U.S. domestic sales, if Buyer elects to export Product, Buyer shall constitute the U.S. Principal Party in Interest or Exporter for all purposes under applicable law. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16. NON-US BUYERS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If Buyer is a natural or legal person of any jurisdiction other than the United States and/or a State thereof, any dispute arising with respect to the transaction(s) specified herein shall be referred to three (3) arbitrators in accordance with the Rules of Arbitration of the International Chamber of Commerce as in effect on the date of such referral. The arbitration shall take place in Houston, Texas, U.S.A. The proceedings shall be in the English language. The American Arbitration Association shall act as appointing authority in the event required. Monetary awards shall be expressed in U.S. Dollars and all awards shall be final and binding on the parties. Judgment upon any award may be entered in any court having jurisdiction.</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17. AMENDMENT; CANCELLATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein.  Except as explicitly set forth in this Agreement, this Agreement and the transaction(s) specified herein can be cancelled only with both parties&#8217; written consent. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18. GOVERNING LAW AND DISPUTE RESOLUTION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parties' rights and obligations hereunder shall be construed and enforced under the laws of the State of Texas, U.S.A., without regard to conflict of laws principles. Incoterms 2010 (or any subsequent revision thereof) ("Incoterms") shall also apply; provided, however, that Incoterms shall apply only to the extent specified in the agreement hereof, and provided, further, that in the event of a conflict between Incoterms and the laws of the State of Texas, U.S.A., the latter shall govern. The parties specifically exclude </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">application of the U.N. Convention on Contracts for the International Sale of Goods.  For any dispute regarding this Agreement, the Parties agree to exclusive jurisdiction and venue in the district courts of Harris County, Texas, or the United States District Court for the Southern District of Texas (Houston Division).</font></div><div style="line-height:120%;text-align:justify;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19. MISCELLANEOUS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No waiver by either party of a right, default or breach of any of the terms and conditions herein shall be effective unless in writing.  No such waiver shall be deemed a waiver of any subsequent right, default or breach (whether similar or dissimilar) except as expressly stated therein. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20. ASSIGNMENT</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Agreement shall not be assigned in whole or in part by Buyer or Seller  without  the written consent of the other party and any attempted assignment without such consent shall be void and of no effect, except that Seller may assign all of its rights and obligations  hereunder to any entity of which Exxon Mobil Corporation owns, directly or indirectly, at least fifty percent (50%) of the shares or other indicia of equity having the right to elect such entity's board of directors or other governing body. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:7px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:7px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:7px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT B </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Master Supply Agreement</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">List of ExxonMobil Affiliates / Divisions</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At its sole discretion and with prior written notice to Buyer, Seller may designate a different selling entity from the ones listed in this Attachment.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">For Product purchases made by Buyer Affiliates in: U.S.A., Brazil, Mexico</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (&#8220;EMCC&#8221;) and/or ExxonMobil Chemical Services Americas, Inc.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22777 Springwoods Village Pkwy</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Spring, TX  77389</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">For Product purchases made by Buyer Affiliates i n: Denmark, France, Germany, United Kingdom, Serbia and Ireland</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ExxonMobil Petroleum &amp; Chemical BVBA (EMPC) </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Polderdijkweg</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">B - 2030 Antwerpen, Belgium</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">For Product purchases made by Buyer Affiliates i n: Singapore, China, India</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ExxonMobil Affiliate:  ExxonMobil Chemical Asia Pacific, a division of ExxonMobil Asia Pacific Pte Ltd (EMCAP)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1 Harbour Front Place #06-00HarbourFront Tower One Singapore 098633</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:508px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT C</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Master Supply Agreement        </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">List of West Pharmaceutical Affiliates</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer may update this list from time to time with written notice to Seller.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Brazil</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Brasil Ltda </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AV Nossa Senhora Das Gracas, 115 </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diadema, Sao Paulo, Brazil 09980-000</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">China</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Packaging (China) Co., Ltd </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No. 111 Tianchen Road</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Qingpu, Shanghai 201707 China</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Denmark</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Denmark A/S </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fuglevangsvej 51 </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Horsens, Denmark</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">France</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">France,S.A. 38, Rue Robert Degon</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Le Nouvion EN Thierache 02170</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Germany</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Deutschland GmbH &amp; Co. KG </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stalberger Str. 21-41</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eschweiler 52249</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Ireland</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Products Ireland, Ltd.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrickpherish Road</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Waterford, X91 R9V6</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">India</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Packaging India Pvt. Ltd.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">900 Peepul Boulevard-Sector 36-Sri City-Satyavedu (P.O) </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chittoor District - A.P. - India - 517 546</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Mexico</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Mexico, S.A. de C.V. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Calle 40 Sur No. 706, </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Esq. 36 Este Civac, </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jiutepec Morelos - </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">M&#233;xicoC. P. 62500</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Serbia</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Beograd d.o.o. Kovin</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Crvenka 76</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kovin 26220, Serbia </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Singapore</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Singapore Pte. Ltd. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15 Joo Koon Circle</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jurong, Singapore 629046</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">U.S.A</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 Herman O. West Drive</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exton, PA  19341-1147</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1028 Innovation Way</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kinston, NC  28504-7616</font></div><div style="line-height:120%;text-align:left;padding-left:28px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">923 West Railroad Street </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kearney, NE 68845-5128</font></div><div style="line-height:120%;text-align:left;padding-left:28px;text-indent:-20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services of Florida, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5111 Park Street North </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">St. Petersburg, FL 33709-1109</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">347 Oliver Street</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jersey Shore, PA&#160; 17740-1923</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:center;padding-left:130px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT D</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:130px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:130px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:130px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Notices</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For all notices, communications, or questions regarding this Contract, the following addresses listed below shall be used; provided, however, that Seller and Buyer can each change any of its address information by providing written notice to the other party.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:10%;"></td><td style="width:51%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ExxonMobil Chemical Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:5px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22777 Springwoods Village Pkwy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 W. Herman O. Drive</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Spring, TX 77389</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exton, PA  19341-1147</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attn: Gerd Merhof</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attn: Oliver Steven</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ExxonMobil Chemical Central Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services Deutschland GmbH &amp; Co. KG</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Im Mediapark 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kiefernweg 5</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50670 K&#246;ln</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52249 Eschweiler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:3px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT E</font></div><div style="line-height:120%;padding-top:3px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Supply Master Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Payment Terms</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer Affiliates shall pay ExxonMobil Selling Affiliates' invoice(s) in full within the days set forth below:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:28%;"></td><td style="width:38%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #939393;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #979797;border-top:1px solid #000000;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Location</font></div></td><td style="vertical-align:top;border-bottom:1px solid #939393;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #000000;"><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Payment Terms</font></div></td><td style="vertical-align:top;border-bottom:1px solid #939393;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #939393;border-right:1px solid #6b6b6b;border-top:1px solid #000000;"><div style="padding-top:3px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Delivery Terms - lncoterms</font></div><div style="text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2010</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #979797;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #909090;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #676767;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">China</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #909090;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #909090;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denmark</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #747474;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #909090;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">France</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #747474;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Germany</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #676767;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">India</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #909090;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #676767;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mexico</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #808080;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #909090;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Serbia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #777777;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #808080;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Singapore</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #808080;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #909090;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.A.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #808080;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #808383;border-top:1px solid #909090;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ireland</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #676767;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #979797;border-right:1px solid #939393;border-top:1px solid #939393;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">* </font><font style="font-family:inherit;font-size:10pt;">For Product sold and/or sourced from the US that is shipped overseas to a non-US location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or any other ExxonMobil Seller to Buyer at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For U.S. sales to Brazil or Mexico, Seller shall constitute the U.S. Principal Party in interest or Exporter for all purposes under applicable law.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:3px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT F</font></div><div style="line-height:120%;padding-top:3px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">West Pharmaceutical Services and ExxonMobil Chemical Company </font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Supply Master Agreement </font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Returnable Metal Crates</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:1px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attachment F documents Buyer's/Buyer Affiliates' responsibility for returnable metal crates ("Metal Crates") used in the supply of Butyl products from Seller/ExxonMobil Selling Affiliates ("ExxonMobil"). Buyer/Buyer Affiliates wishes to receive Butyl in Metal Crates and ExxonMobil is willing to supply Butyl in Metal Crates, subject to the following agreement.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Agreement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer/Buyer Affiliates is responsible for the Metal Crates in their custody at the replacement value of the Metal Crates. Buyer's /Buyer Affiliates' custody begins when Metal Crates are loaded onto the delivering carrier at the ExxonMobil or third party warehouse and ends when Metal Crates are loaded onto the carrier for return to Global Pallet Services Limited (GPS) USA, Inc.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer/Buyer Affiliates must implement a system to ensure Metal Crates are not lost or damaged, and are returned in undamaged condition (normal wear and tear excepted).  Buyer/Buyer Affiliates will supply to ExxonMobil upon request copies of any Bills of Lading needed to verify return shipments of Metal Crates.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For each Metal Crate not received back at Global Pallet Services Limited (GPS) and where a physical inventory determines that such Metal Crate is not in the custody of Buyer/Buyer Affiliates, Buyer/Affiliates will have 30 days from end of the calendar year to reimburse ExxonMobil as stated below.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the purposes of this agreement, a Metal Crate is considered to be in undamaged condition if the base and all four sides are in working condition.   Buyer/Buyer Affiliates agrees to pay for all repairs for damage to any Metal Crate, or to pay the replacement charge of $[*****] per Metal Crate for any Metal Crate that is either permanently lost or damaged beyond repair while in the custody of Buyer/Buyer Affiliates, and a replacement charge ($[*****] per door) for any removable door missing from Metal Crates collected at Buyer's /Buyer Affiliates' location. A Metal Crate shall be deemed to have been damaged beyond repair if the documented repair costs to restore the damaged Metal Crate to fit-for-fill condition would exceed $[*****]. In addition, if any of the charges imposed by Global Pallet Services Limited (GPS) under the agreement between the ExxonMobil and Global Pallet Service Limited (GPS) for damage to or loss of Metal Crates, are revised, the aforesaid amount reimbursable by Buyer/Buyer Affiliates shall automatically be revised in similar manner.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:3px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT G</font></div><div style="line-height:120%;padding-top:3px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Master Supply Agreement</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:136px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMCAP STANDARD TERMS AND CONDITIONS OF SALE AND ACCEPTANCE OF ORDER</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACCEPTANCE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acceptance of Buyer's order by Seller is expressly made conditional upon Buyer's assent to these Standard Terms and Conditions of Sale. Terms as specified in Seller&#8217;s Order Confirmation (if any) and these Standard Terms and Conditions shall constitute the only binding contract terms and conditions between the parties (the &#8220;Agreement&#8221;) in the absence of a written agreement as described in the Clause on Written Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WRITTEN AGREEMENT</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If there is an executed written sales contract or agreement in effect between Buyer and Seller covering Buyer&#8217;s order, the terms and conditions of that contract or agreement shall prevail over any conflicting term in Seller&#8217;s Order Confirmation and/or these Standard Terms and Conditions and/or Buyer&#8217;s purchase order.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRICE ADJUSTMENT</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****] Buyer's failure to deliver to Seller written objection to any such change at least ten (10) days before its effective date shall constitute acceptance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If Buyer does deliver such objections within the deadline, no delivery shall be made until parties agree on the new price, freight and/or payment terms.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[*****]</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUANTITY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quantity of all shipments shall be determined by Seller and shall have a shipping allowance of plus or minus five percent (+/-5%) of the quantity indicated in Seller&#8217;s Order Confirmation or separate sales contract, or such other percentage as determined by Seller. To allow for standard tolerances of scales, Seller will not consider any claims for shortages of less than one half of one percent (0.5%) of the gross weight of any shipment of packaged product or less than one half of one percent (0.5%) of the net weight of bulk shipment. Seller shall have the right at all times to appoint an independent surveyor.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">TAXES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All prices are exclusive of taxes, duties, or other governmental charges levied on or in respect of the product or delivery thereof. Buyer shall pay or reimburse Seller for such taxes, duties or charges. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISK AND TITLE TRANSFER</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk of loss of and damage to product shall pass to Buyer in accordance with the Incoterm specified in Seller&#8217;s Order Confirmation or separate sales contract. Without negating Seller&#8217;s warranty obligations hereunder, Buyer assumes all risk and liability for loss, damage, or injury to the person or property of Buyer or other parties arising out of the use or  possession of any Product sold hereunder.  Unless stated otherwise in Seller&#8217;s Order Confirmation or separate sales contract, title in product shall pass to Buyer simultaneously with risk of loss of and damage to product. However, if the product is shipped by Seller from the US, such title and risk shall pass to Buyer at the first point at which the delivering vessel crosses the outer boundary of the US Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea or as such term is used in the said Convention.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WARRANTIES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are no warranties which extend beyond the description on the face hereof, and Seller makes no warranty, expressed or implied, of satisfactory quality, merchantability, fitness for any particular use or otherwise, except that the products sold hereunder shall meet Seller's applicable standard specifications or such other specifications as may be notified by Seller to Buyer from time to time.  Buyer assumes all risk whatsoever as a result of the use of the products purchased, whether used singly or in combination with other substances or in any process.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Without limiting the foregoing, Seller does not recommend nor endorse the use of product in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product&#8217;s use in any medical application.  Buyer represents and warrants that no product purchased hereunder will be </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">used or resold for use in any commercial or developmental manner in connection with medical applications without Seller&#8217;s prior express written acknowledgment. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of product purchased hereunder in any medical application.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIMITATION OF CLAIMS</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Seller's total liability for all claims arising hereunder or connected with the products sold hereunder, whether based in contract, tort or otherwise, shall be no greater than an amount equal to the purchase price of the products to which any such claims relate, or at the Seller's option, and only in the case of claims regarding defective or non-conforming product, to replacement of such products, provided that in all cases Buyer shall be under an obligation to mitigate any loss as far as possible.  Seller shall not in any event be liable for any special, incidental, exemplary or consequential damages.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Clauses on Quantity, Transfer of Risk and Title Transfer, Buyer shall inspect and test product delivered hereunder for damage, defect or shortage immediately upon receipt and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt.  Any claim must be accompanied by documents as required by Seller, including but not limited to</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;">&#32;</font><font style="font-family:inherit;font-size:10pt;">a certified weigh scale ticket or an independent surveyor report, and Seller shall have an opportunity to an independent assessment.  All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives complete written details of such claim not later than [*****] after Buyer's receipt of product as to which such claim is made.  Receipt will be deemed to have taken place for purposes of this subparagraph when the product has been loaded onto Buyer&#8217;s transport, or offloaded from the vessel or other means of transport on which delivery has been made when delivery is arranged by Seller.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LAYTIME AND DEMURRAGE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buyer shall unload tank containers, cars, trucks and barges furnished by Seller and clear products from port, or at delivery destination, within the free time specified by tariffs or time periods on file with applicable bodies, or promptly after receipt if no such tariffs or time periods are on file.  Buyer shall pay charges resulting from its failure to do to Seller or directly to the common carrier upon receipt of invoice.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For bulk marine shipment, demurrage charge at load port is for account of Seller and at discharge port for Buyer&#8217;s account.  For sales other than FOB sales, laytime allowed, demurrage rate and applicable charter party terms shall be as specified in Seller&#8217;s vessel nomination to Buyer failing which, the terms in Seller&#8217;s contract of affreightment with the vessel owner shall apply and Buyer shall pay Seller or the carrier the demurrage incurred at the discharge port by Seller&#8217;s stipulated deadline. Subject to the foregoing, for the first discharge terminal, laytime shall commence six (6) hours after the vessel&#8217;s notice of readiness is tendered to Buyer (or its agent) or upon the vessel being all fast to the discharge terminal, whichever occurs first, and for subsequent discharge terminal(s), laytime shall commence immediately when the vessel&#8217;s notice of readiness is tendered to Buyer (or its agent). Laytime shall cease upon disconnection of all cargo hoses upon completion of discharge. For FOB sales, vessels nominated by Buyer are subject to Seller&#8217;s screening, inspection and acceptance process and Seller&#8217;s agreement to loading-date range duration / loading-date range narrowing profile / loading-date range communication leadtime and other shipping logistics, and any claim for demurrage by Buyer shall be waived unless notice in writing of such claim is received by Seller with full supporting documentation (including the invoice and time sheet issued by the vessel) by Seller&#8217;s stipulated deadline. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAILURE IN PERFORMANCE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Failure by Seller to deliver on a specific date shall not entitle Buyer to repudiate this Agreement.  Buyer shall not be relieved of any obligations to accept or pay for products by reason of any delay in delivery or dispatch.  Furthermore, no liability shall result to either party for delay in performance or non-performance of an obligation hereunder (except an obligation to make payment) in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, shortage or inability to obtain product or raw material for product, or good-faith compliance with any governmental order or request (whether valid or invalid) .  Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of product or feedstock for making product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirement and/or its obligation to its customers, Seller's obligation to deliver product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not)  such products as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s)  from which deliveries like those covered hereby are normally shipped.  Seller shall not be obligated to purchase or obtain product, or feedstock to make product, to replace deliveries omitted or curtailed under this Paragraph.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MODIFICATION AND AMENDMENTS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are no oral understandings, representations or warranties between the parties that conflict with these Standard Terms and </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conditions or the details of price, payment, shipment or delivery schedule as communicated by Seller.  No modification of any Standard Terms and Conditions shall be of any force or effect unless such modification is in writing and signed by the party to be bound thereby, and no modification of the same shall be effected by the acknowledgement of Buyer&#8217;s purchase orders or equivalent forms containing terms and conditions at variance with those set forth herein</font><font style="font-family:inherit;font-size:10pt;color:#00b050;font-style:italic;">&#32;</font><font style="font-family:inherit;font-size:10pt;">and all such terms or conditions in Buyer&#8217;s purchase orders or equivalent forms shall be considered null and void.</font><font style="font-family:inherit;font-size:10pt;color:#00b050;font-style:italic;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOVERNING LAW</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Agreement shall be governed by Singapore law, without regard to its conflict of laws principles. Parties agree to exclude the application of the United Nations Convention on Contracts for the International Sale of Goods. A party that is not a party to this Agreement shall have no rights under the Contracts (Rights of Third Parties) Act (Cap 53B) to enforce any of the terms in this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASSIGNMENT</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Agreement shall not be assigned, in whole or in part, by either party without the prior consent of the other party, but shall be binding upon and shall inure to the benefit of the legal successors of the respective parties hereto; except that Seller may assign this Agreement, in whole or in part, to any affiliate.  For purposes of this Clause, an "affiliate" of Seller means the ultimate holding company of Seller or any corporation of which fifty percent (50%) or more of the outstanding stock is held directly or indirectly by such ultimate holding company. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DEFINITION</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the extent not inconsistent with the terms hereof, Incoterms 2010 (&#8220;Incoterms&#8221;) shall apply hereto.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NO WAIVER</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">No waiver by either party of any breach of these Standard Terms and Conditions shall be construed as a waiver of any succeeding breach of the same.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CREDIT CLAUSE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If Buyer fails to make payment when due or if Seller reasonably believes the financial status of Buyer is impaired due to any reason, Seller shall have the right, without prejudice to its other rights in contract or at law, upon notice to Buyer, to withhold further deliveries of product, modify or change any terms of payment or credit, suspend performance under this Agreement, accelerate payment obligations such that all amounts owed under prior deliveries and not paid shall become immediately due and payable, require Buyer to furnish security as deemed appropriate by Seller and/or exercise rights against any collateral and apply the proceeds against amounts due and owing. Seller shall in any event have the right to set-off any claim that Seller (or its affiliate) may have against Buyer (or its affiliate), against any sum which Seller may owe to Buyer (or its affiliate). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event Seller requires a documentary letter of credit or a standby letter of credit, such letter of credit shall be issued by an international bank in form and substance acceptable to Seller. A clean letter of credit is to be received by Seller prior to the estimated shipment date or by such date as Seller shall agree.  Seller shall have no obligation to deliver product if the letter of credit is not so received by Seller.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Without prejudice to Seller's other rights in law and contract, it is agreed that Buyer shall indemnify and hold harmless the Seller from and against any dead-freight, vessel and/or port charges and payments, demurrage and/or any damages, losses or expenses incurred as a result of any delay in loading or non-delivery of any product under this Agreement arising from Buyer's failure or delay in providing the letter of credit in accordance with the terms of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BUSINESS PRACTICES</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business Standards.   Each party to this Agreement shall establish precautions to prevent its employees or subcontractors from making, receiving, providing or offering any substantial gifts, extravagant entertainment, payments, loans, or other considerations to the employees of the other party and/or their families and/or third parties in connection with this Agreement.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compliance With Law.  Each party agrees and will secure agreement by its subcontractors to comply with all applicable laws, regulations, decrees and judicial orders.  Notwithstanding anything in this Agreement to the contrary, no provision shall be interpreted or applied so as to require any party to do, or refrain from doing, anything which would constitute a violation of, or result in a loss of economic benefit under, United States anti-boycott and other export laws and regulations.  Each party represents to the other party that it shall not make any improper payments of money or anything of value to a government official (whether appointed, elected, honorary, or a career government employee) in connection with this Agreement, nor shall it make improper payments to a third party knowing or suspecting that the third party will give the payment, or a portion of it, to a government official.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notice of Non-Compliance.  Each party ("the Relevant Party") agrees to notify the other party promptly upon discovery of any instance where the Relevant Party fails to comply with this Clause.  If either party discovers or is advised of any errors or exceptions related to its invoicing under this Agreement, both parties will together review the nature of the errors or exceptions, and will, if appropriate, promptly take corrective action that is necessary on its part and adjust the relevant invoice or refund overpayments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:136px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:136px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:3px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ATTACHMENT H</font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates </font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019-2023 Global Master Supply Agreement</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMPC STANDARD TERMS AND CONDITIONS OF SALE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(hereafter referred to as &#8220;EM&#8221;)</font></div><div style="line-height:120%;text-align:center;padding-left:142px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1. Agreement(s) as used herein shall mean any order confirmation issued by EM or any other contractual arrangement between EM and Buyer. These general terms and conditions shall apply to and form part of all Agreements. The Agreement constitutes the complete and entire understanding and agreement between EM and Buyer. No other general terms and conditions will have an effect on the Agreement. Deviations from the Agreement, including these general terms and conditions, shall be valid only if</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">expressly agreed in writing by the parties. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2. Title to the product shall transfer from EM to Buyer simultaneously with the transfer of risks as per Incoterms. All references to Incoterms shall mean ICC Incoterms 2010.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3. EM will use reasonable efforts to meet the planned delivery date which shall be deemed to be only approximate.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4. If Buyer is responsible for the transport of products, Buyer shall ensure that the means of transport is clean and dry, suitable for loading and carrying the products, and complies with the safety standards of EM and with the legal standards for such means of transport. In case of non- or incomplete compliance with the above requirements, EM will be entitled not to load or cause to load this means of transportation, without any obligation to compensation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5. If delivery takes place on reusable pallets (regardless of whether they are property of EM), Buyer will maintain these pallets in good condition and make them available on request for collection by or on behalf of EM.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6. EM&#8217;s determination of quantity and quality shall be binding for both parties.  Without prejudice to the foregoing, Buyer has the right to have a representative present at said determination, at his own cost.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7. Products shall be supplied by EM at the price valid on the planned delivery date.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8. Prices are exclusive of taxes (such as VAT), duties or other governmental charges. In addition to the price of the product, EM shall have the right to charge any taxes, duties or other governmental charges that now or in the future may be levied, in connection with the manufacture, sale, transportation, storage, handling, delivery, use, possession of or disposal of the product or raw materials used in it. VAT and excise tax exemptions granted on request of Buyer in accordance with legislation or administrative regulations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">imposed by any lawful authority, shall be the exclusive responsibility of Buyer who shall indemnify EM in respect of any VAT or excise Tax liabilities arising therefrom.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9. EM will invoice Buyer and Buyer will pay the invoice in the currency stated on the invoice, without any discount, deduction or set off, so that EM&#8217;s designated bank account is credited with the full invoiced amount within 30 days from the invoice date.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10. Failure by Buyer to pay on the due date shall make all sums owing by Buyer to EM on any account whatsoever immediately and automatically due and payable, without prejudice to EM's right to charge automatically and without giving any notice the statutory late payment interest rate as defined in applicable legislation on combating late payment in commercial transactions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11. EM and any of its Affiliates (as herein defined) may at any time without giving notice to or making demand upon Buyer, set off and apply any and all sums at any time owing by EM and/or by any of its Affiliates to Buyer or any of Buyer&#8217;s Affiliates, against any and all sums owing by Buyer or any of Buyer&#8217;s Affiliates to EM and/or to any of its Affiliates. An Affiliate is (1) for EM: Exxon Mobil Corporation or any company in which Exxon Mobil Corporation owns or controls, directly or indirectly, 50 % or more of the voting stock and (2) for the Buyer: any company in which its ultimate holding company owns or controls, directly or indirectly, 50 % or more of the voting stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12. If one party has objective reasons to conclude that the financial status of the other party becomes impaired or unsatisfactory, or in case of late payment, it may require the other party to provide adequate securities, including cash in advance, for the timely payment of future deliveries, absent which it may suspend its supply obligations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13. Health and safety information relating to handling and use of products are in the Safety Data Sheets (SDS) that EM has sent or will send to Buyer. Buyer shall notify EM if Buyer has not received such information by the delivery date. EM will assume that Buyer has received the necessary information absent notification from Buyer. Buyer shall provide such health and safety information to anyone including without limitation its employees, contractors, agents or customers who may be exposed to the</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">product. Buyer warrants that it possesses the necessary expertise for handling products of the type being supplied hereunder and that it will take the steps necessary to review and understand that information contained on the SDS for each product it purchases. Such data and statements are offered only for Buyer's and its users' and customers' considerations, investigation and verification.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14. EM gives no guarantees or warranties, express or implied, as to the quality, merchantability, fitness for purpose or suitability of the products except that the product sold pursuant to the terms of this Agreement shall meet the relevant EM standard specification in force at the time of loading or such other specification or requirement which may be explicitly agreed in writing between the parties. Without limiting the foregoing, EM does not recommend nor endorse the use of product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product(s)&#8217; use in any medical application. Buyer represents and warrants that no product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without EM&#8217;s prior express written acknowledgement. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that EM recommends or endorses the use of product(s) purchased hereunder in any medical application. EM's maximum liability for all claims for any reason is the sales price of the product involved and EM shall not be liable for indirect or consequential damage. Claims by Buyer are waived unless made in writing within 150 days from date of (non-) delivery. Buyer shall indemnity and hold EM harmless in respect of all claims for which Buyer is liable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15. EM makes no representation or warranty of any kind, express or implied, that the products sold hereunder, or the use of such products, or articles made therefrom, either alone or in conjunction with other materials, will not infringe any patent or trademark rights. Buyer agrees that it will promptly notify EM of any claim or suit involving Buyer in which patent or trademark infringement is alleged with respect to the products sold hereunder, and that Buyer will permit EM, at its option and expense, to control completely the defence or settlement of any such allegation of infringement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16. Neither party shall be liable for any delay in performance or non-performance in whole or in part caused by circumstances beyond the reasonable control of the party affected including but not limited to, acts of God, fire, flood, war, terrorist activity, or the threat of one of these events, criminal acts or sabotage, diminishment or failure of power, telecommunications, data systems or networks, accident, explosion, equipment breakdowns, labour disputes, shortage or inability to obtain energy, utilities, equipment, transportation, the Product, or the feedstock from which the Product is directly or indirectly derived; or good faith compliance with any regulation, direction r request (whether ultimately determined to be valid or invalid) made by governmental authority or any person or persons purporting to act for such an authority.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Regardless of the occurrence or non-occurrence of any of the circumstances set forth above, if for any reason, supplies of or distribution logistics of the Product deliverable under this Agreement or of the feedstock from which the Product is directly or indirectly derived from any of EM's then existing sources of supply are curtailed or cut off, or otherwise inadequate to meet EM&#8217;s own requirements and its obligations to its customers, EM shall have the option during such period of curtailment, or cessation to apportion fairly among its customers including EM&#8217;s Affiliates and whether under contract or not, such Product as may be received in the ordinary course of business or manufactured at EM then existing sources.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EM shall not be obliged to purchase or otherwise obtain alternative supplies of product deliverable under this Agreement, or the feedstock from which product directly or indirectly is derived. Nor shall EM be obliged to settle labour disputes, run down inventories below normal levels, adapt or vary its manufacturing plan except at its own sole discretion, or to take any steps other than in accordance with good business practice to make up inadequate supplies or to replace the supplies so curtailed or cut off.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EM shall not be obliged to make up deliveries omitted or curtailed under this Agreement. Any such deficiencies in deliveries shall be cancelled with no liability to either party, it being agreed, however, that a force majeure situation hereunder shall not entitle either party to cancel this Agreement.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17. In case of any material breach of the terms and conditions contained in the Agreement by one of the parties, the other party may, without giving prior written notice in the event the material breach is not cured within such notice period or without undertaking any recourse to legal proceedings, suspend its further performance, terminate the Agreement or require specific performance by the other party of the Agreement in whole or in part, without prejudice to its right to damages for any losses incurred subject to Article 14.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18. Neither party may assign this Agreement without the written consent of the other party save in the case where such assignment is to an EM Affiliate and prior written notice has been given to the Buyer. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19. EM informs Buyer that any information relating to an identified or identifiable natural person (&#8220;individual&#8221;), in particular business contact details of Buyer&#8217;s personnel and contractors, which is communicated by or on behalf of Buyer to EM (&#8220;personal data&#8221;), will be subject to data processing by EM. To learn more about the processing of personal data and about individual&#8217;s rights in relation to the processing, read the EM data privacy notice at http://www.exxonmobil.be/enbe/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the EM data privacy notice.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20. Notwithstanding any other provision in this Agreement or any other document, neither this Agreement nor any other document shall constitute an agreement by EM to take any action or refrain from taking any action that is in conflict with, penalized under or compliance with which is prohibited by the laws or regulations of the United States, the European Union (EU), any EU member State, the United Kingdom and/or Norway, as applicable. The parties furthermore represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti-money laundering laws, rules and regulations of any government relevant to the transaction, including the US Foreign Corrupt Practices Act and the applicable country legislation implementing OECD Convention on Combating Bribery of Foreign Public Officials in international business transactions as such laws and regulations may be updated or amended from time to time.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21. To the extent permitted by law, in the event that a party becomes aware that it will or may undergo a Change of Control (&#8220;Affected Party&#8221;) within the following three (3) Months, the Affected Party will notify the other party without delay after it becomes so aware. Together with such notification, the Affected Party will supply the other party with sufficient information to allow that other party to reasonably assess the impact that such Change of Control may have on it and/or its Affiliates, on the Affected Party&#8217;s creditworthiness, and on the Affected Party&#8217;s ability to perform its obligations under this Agreement. In the event that the other party concludes in its sole discretion that such Change of Control, if it is implemented:</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) may result in it and/or its Affiliates being subjected to any fact, matter, event, circumstance, condition or change which materially and adversely affects, or could reasonably be expected to materially and adversely affect, individually or in aggregate, the business, operations, assets, liabilities, condition (whether financial, trading or otherwise), prospects or operating results of it and/or its Affiliates;</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(b) that the Affected Party&#8217;s creditworthiness may be reduced; and/or</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(c) that the Affected Party&#8217;s ability to perform its obligations under the Agreement may be negatively affected;</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">then the other party may (but is not obliged to) terminate this Agreement forthwith upon notice to the Affected Party. Such termination is without prejudice to the rights and obligations of the parties that have accrued up to and including the date of termination.</font></div><div style="line-height:120%;text-align:justify;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As used above, "Change of Control" means any of the following: </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) any transaction, or series of transactions, that would result in the transfer of at least fifty percent (50%) of the equity interest in a party (or of at least fifty percent (50%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in a party ("Party&#8217;s Parent")) to a single transferee or multiple transferees under common control; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) any transaction that would result in a Party&#8217;s (or Party&#8217;s Parent's) merging with one or more other entities.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22. This Agreement between EM and Buyer shall be governed by the laws of Belgium (excluding its rules on conflict of laws). Neither the Uniform Law on the International Sale of Goods ('ULIS'), nor the United Nations Convention on Contracts for the International Sale of Goods 1980 ('CISG') shall apply.</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(i) If Buyer's registered office is located within the territory of the European Economic Area ('EEA'), any disputes between EM and Buyer arising out of or in relation to this Agreement shall be of the exclusive jurisdiction of the Courts of Antwerp.</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(ii) If Buyer's registered office is located outside the territory of the EEA, any disputes arising out of or in relation to this Agreement shall be finally settled under the CEPANI Rules of Arbitration by three (3) arbitrators appointed in accordance with said Rules. The seat of the arbitration shall be Brussels. The arbitration shall be conducted in the English language.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* Further information on ExxonMobil Petroleum &amp; Chemical BVBA is available on:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:584px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>wst-20200110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.westpharma.com/20200110" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wst="http://www.westpharma.com/20200110" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20200110_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20200110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20200110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wst-20200110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="DocumentAndEntityInformationDocumentAndEntityInformation" roleURI="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="wst_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>wst-20200110_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="wst-20200110.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>wst-20200110_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="wst-20200110.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>wst-20200110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047_label_en-US" xlink:label="lab_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047_documentation_en-US" xlink:label="lab_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:href="wst-20200110.xsd#wst_DocumentAndEntityInformationAbstract" xlink:label="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="lab_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:to="lab_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8_terseLabel_en-US" xlink:label="lab_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8_label_en-US" xlink:label="lab_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:to="lab_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:to="lab_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0_label_en-US" xlink:label="lab_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:to="lab_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:to="lab_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03_label_en-US" xlink:label="lab_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:to="lab_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:to="lab_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:to="lab_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:to="lab_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:to="lab_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:to="lab_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166_label_en-US" xlink:label="lab_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:to="lab_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:to="lab_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A_label_en-US" xlink:label="lab_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:to="lab_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9_label_en-US" xlink:label="lab_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:to="lab_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:to="lab_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36_label_en-US" xlink:label="lab_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:to="lab_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493_label_en-US" xlink:label="lab_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:to="lab_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568_label_en-US" xlink:label="lab_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:to="lab_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:to="lab_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A_label_en-US" xlink:label="lab_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:to="lab_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>wst-20200110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="wst-20200110.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="wst-20200110.xsd#wst_DocumentAndEntityInformationAbstract" xlink:label="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityCentralIndexKey_9F40D81F1969ECE4DE76A9F26E0A6366" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_DocumentType_43E66BA9AB00801CCB0BA9F26E0B46A8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_DocumentPeriodEndDate_E3F9C0732AEDF08DFFD4A9F26E0BE0EE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityRegistrantName_F4BF129EBF6E5F80AAA9A9F26E0BD4D0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13A23D4BFDAA170748A3A9F26E0C4553" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityFileNumber_9740F0F69F6E6076068EA9F26E0C8C03" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityTaxIdentificationNumber_312A003F64EE4F6E73A2A9F26E0CA8E1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityAddressAddressLine1_A8C18077EC2BB05CBC11A9F26E0CB14E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityAddressCityOrTown_F97A814FB51E9D917613A9F26E0C14BE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityAddressStateOrProvince_603029A71D9E5E52AF91A9F26E0C7C96" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityAddressPostalZipCode_62009536144811ECC60BA9F26E0D25D6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_CityAreaCode_796617B2163717A436ACA9F26E0DE166" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_LocalPhoneNumber_A44A9FDB021E7C29FF4CA9F26E0D3F7D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_WrittenCommunications_76EC247FA3A365F6A188A9F26E0D6C0A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_SolicitingMaterial_898293876CBE8B2C2969A9F26E0E0FF9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_PreCommencementTenderOffer_0378FDD1342146F324B8A9F26E0EC601" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_E9CA9850C8F9B6E1E85FA9F26E0E2D9F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_Security12bTitle_14414D6D7713BCBCED0EA9F26E0EBC36" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_TradingSymbol_FA8F9F0684B5E27692F3A9F26E0E5493" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_SecurityExchangeName_3839B6F99C5FEEAA45B7A9F26E0E2568" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_EntityEmergingGrowthCompany_FBC4AABA12731A0F97E0A9F26E0E6E2F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_wst_DocumentAndEntityInformationAbstract_6B19BD4A3F1DC91BE095A9F26E056047" xlink:to="loc_dei_AmendmentFlag_546D281ABE695C3C4C32A9F26E0FC11A" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>form8k01102020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form8k01102020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[  11'5C:WD  0 $    /   _]L 0P "
M 0$" 0$" @(" @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH-
M"@H+# P,# <)#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
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M_P"(60Z8A_\ @/\ P3\F_P"(I3O_ +NO_ O^ ?UJ>'OB_P"%?%FK1V.F>)=
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M ./5WW[+?_!N5H_[-/[1W@OX@/\ %C5_$+>#M334X].?08;=;IT5@H:02L5
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M898[>$A596R&4S2P@@^M?6YCC8X3#3Q4]5!-_<?(Y7@I8O%0PT-YNWWGSO\
M WP6GQE^-O@WPC!/"\OB;6[/30 0W$LRJV0.3\I.:_K#TG3X='TR&SMT2*WM
M(UAB5>B(JA0OX "N3T3]G+X=^%]3M]3T[P)X.T^_M'$MO=6VCV\4T+]F5E0$
M'W!KPK_@J)_P4W\/?\$ZOA*D\:V^N?$#7XG7P_H!D(\TC@W<^WE+>,]3U=B%
M'.2/P;/L\K<18FC0PU)IJZ2O>[=M>G8_>L@R2CP]AJM;$U$T[-NW1=/Q-?\
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M)J?[0?B6P28;QM^&LS$+C@?\?1Y-=QX:_9@_9)U!RMY^U#XKB^4<_P#"O98
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M?:O\7_'VA>$M!1'UOQ3J5OHVG[P=BSW$JQ(S8YVJ6W-C^%6/:LL@XR*^[O\
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M_9B;Q#\2?'/Q;OH2;?P_;)H&DDKPUQ-\]PX/^RBQK_VTK]8OVJ_AE/\ &?\
M9:^(_@^V.VZ\5^&-2TB(XSAY[62)?U85^&<>YK&OF]/#7]VE:_JVF_PL?NO
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MVX6/9N^8;GFWC>0<>G%>$K_P=561C!_X43J(X_Z&Z+_Y%KZ8_P""AOP%T_\
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MK;S3_,_-\]\.H8FK+$8*?(WJXM:7\F?S$XR,Y_*FR,(CG( SSGC%?T/W/_!
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MGAW5P>-IXJM5C)1=[*_ZG?1_=7Z5)4<?"J#U%25^4(_5R"\)&T@X((K\&_\
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B+3H?6T4(B<8STJ53D445YAZG86BBBF 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8kexxonsupplyagree.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8kexxonsupplyagree.htm">form8kexxonsupplyagree.htm</File>
    <File>exh101exxonsupplyagree.htm</File>
    <File>wst-20200110.xsd</File>
    <File>wst-20200110_cal.xml</File>
    <File>wst-20200110_def.xml</File>
    <File>wst-20200110_lab.xml</File>
    <File>wst-20200110_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8k01102020.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6636294080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_wst_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000105770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WEST PHARMACEUTICAL SERVICES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-1210010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">530 Herman O. West Drive,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Exton,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19341-0645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">594-2900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.25 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wst_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wst_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>11
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8kexxonsupplyagree.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "wst-20200110_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wst-20200110_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "form8kexxonsupplyagree.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wst-20200110_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wst-20200110_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "wst-20200110.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "wst",
   "nsuri": "http://www.westpharma.com/20200110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8kexxonsupplyagree.htm",
      "contextRef": "D2020Q1Jan10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Document and Entity Information Document and Entity Information",
     "role": "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation",
     "shortName": "Document and Entity Information Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8kexxonsupplyagree.htm",
      "contextRef": "D2020Q1Jan10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.westpharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "wst_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.westpharma.com/20200110",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O*NQZ8_?V'QM?!&4+O^Y"?@%02P,$%     @ _8DP4)E<G",0!@  G"<
M !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T
M$W-I=MNTF83M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY
M\^XN8NB&B)3R>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2
MP]R"BPA+>!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA
M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M
M&N#C\7@XMLO2BW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_K
MFVB<"HU;3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K
M>A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T
M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)
MI#-ZG7TZSFN4?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R
M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M99TWBISN]F>HQ:#>S@7WOT3Q U!+ P04    " #]B3!0%FTC?T,!   \ @
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MP    !,"   +              "  0    !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( /V),% GZ(<.@@   +$    0              "  >D   !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ _8DP4(YAEQ_O    *P(  !$
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M:@X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #]B3!0%FTC?T,!   \ @
M#P              @ %L$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M_8DP4/_ )@B]    A0(  !H              ( !W!$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ _8DP4 N/V ,A 0  5P0  !,
M             ( !T1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      H
,"@"  @  (Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>form8kexxonsupplyagree_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wst-20200110.xsd" xlink:type="simple"/>
    <context id="D2020Q1Jan10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000105770</identifier>
        </entity>
        <period>
            <startDate>2020-01-10</startDate>
            <endDate>2020-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1Jan10"
      id="Fact-99E0C554F1F4A1249AA1A9F26E2E3C80-wk-Fact-99E0C554F1F4A1249AA1A9F26E2E3C80">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1Jan10"
      id="Fact-9944FE10589927B82154A9F26E2D8B7D-wk-Fact-9944FE10589927B82154A9F26E2D8B7D">0000105770</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q1Jan10"
      id="d120335582e123-wk-Fact-9E73DC91627A594FBD18A9F26E118803">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1Jan10"
      id="d120335582e141-wk-Fact-D1DD157B6FF0615670DDA9F26E103813">2020-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1Jan10"
      id="d120335582e160-wk-Fact-2BF25DBCE68F72608DB5A9F26E2AAD3B">WEST PHARMACEUTICAL SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1Jan10"
      id="d120335582e219-wk-Fact-5DDDF12B45FB99C128E8A9F26E183B91">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1Jan10"
      id="d120335582e239-wk-Fact-8221ECE2757BED81FB8AA9F26E183346">1-8036</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1Jan10"
      id="d120335582e249-wk-Fact-AD37F401C67F3F58AE7EA9F26E18AFA5">23-1210010</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1Jan10"
      id="d120335582e333-wk-Fact-978DD8B8F59FBF9F1373A9F26E17539D">530 Herman O. West Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1Jan10"
      id="d120335582e338-wk-Fact-CA2F25F701CCAF99E91EA9F26E17BBE8">Exton,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1Jan10"
      id="d120335582e343-wk-Fact-2717BAC9949AC136843CA9F26E18D639">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1Jan10"
      id="d120335582e363-wk-Fact-3D2E1FEFE9033C2D9CF2A9F26E179B6F">19341-0645</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1Jan10"
      id="d120335582e404-wk-Fact-97E0CCF5AEA88F39FCB4A9F26E1010A4">610</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1Jan10"
      id="d120335582e409-wk-Fact-E4DA183C2C5BCF984036A9F26E10231D">594-2900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q1Jan10"
      id="d120335582e450-wk-Fact-6940C6DEE86FD13BBD7DA9F26E213009">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q1Jan10"
      id="d120335582e469-wk-Fact-E127CAD935C6134B91EAA9F26E235EA3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1Jan10"
      id="d120335582e488-wk-Fact-EC5A2F5001C5CC10EA70A9F26E1E4E1F">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1Jan10"
      id="d120335582e507-wk-Fact-1CBC94AA3A127D9E2BA8A9F26E1522FD">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q1Jan10"
      id="d120335582e546-wk-Fact-221C0AE6CCFF5D8C2BC7A9F26E2730CF">Common Stock, par value $0.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1Jan10"
      id="d120335582e551-wk-Fact-5992DD38E1EE4DE0F8A1A9F26E2606E8">WST</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1Jan10"
      id="d120335582e556-wk-Fact-C676FF440C68D3B32718A9F26E264370">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1Jan10"
      id="d120335582e564-wk-Fact-FDFC846D40A2FB096049A9F26E10B048">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000105770-20-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000105770-20-000002-xbrl.zip
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MQ%2:@/Q!CD2\%YE$=?MA20DL$-G 9:2Y8C*.8"%7NU%]+<>UFV+5I+8.Y+Y
M+@VF86":7Y+T$E#Y7/%)XO'I"%:3&=;$3D1H*M>U4!=8'!M8//)XA- R5AZ)
M:<*[N+!XM%1P$D)A1G"(*V1JI#)871'V9"I*&AZ2Z +$#>@R@-# GQ$C490
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M8R1&03*1\!\E+M"BP<8$*883Z*(4U0 Q3 O4'&<6.:MZ2P=G;6I4,3N@XZ0
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M=(XZQP-QVNEU3_;KC:R8+%;XB'U R'?B'S(I,'1+O11WWM:;54D:P3*GA#4
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M HN"E"+%G#IKE066H8C1"& 4I4 FUEUGA/X8Y@PYI(:*"M9*3.#3.;L=P4H
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MB=4'E1PEU]RI*>#$Y 0V'V ,"^6U?2)7,]8GALY@38M<DPUU3@YG/*P 15'
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MW#<!X![+N'>:.#&IW:&"FG^>M8X'W<%O[^UW^_\XZP]0%-RB_^\#-;OGDFU
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MQ'2<)K";8(]&<0.X4 YO99()J4P>=IZ0 =V=!B&]O0Z5AF,:VMRA2#-;U>R
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M) @=H,#V.$HD2HTPDNM"8@[<=V*IU&MI8 VGDJI;EDI6LXQWF3@%%>\P#Y%
MVZW3S=66CV'QPS M,N"#>.\I%2+_M/UJ:WO;_,(_#+#_E#A)5'EB8OOMFU=[
M>W_L^KL:@!J &H :@!J &H :@!J &H :@!J &H :@!J 1Y[I,@] I?/ R^TW
M3V38SGH"4&?7W'MVS3KASH_)I6D_UNA\G4ISOZDTPOQOW>#_RT\[K[;?/_2_
MU^VM;:[.,E0LXR-/2'.X!P#*V;G%-.1.LA$GP)B<&!S=ABW3\+^4>;.8<\/)
M-JM.27A,$3U.:5GI=EW+KP$^#7SZ, _E:@^U]:LX3K66 %HRAIT4^U*+CYFD
M/)B=G9>KA6X_DCB>LR'Z,A6GLHA3FZTDMM^^?;.]M;V]7;.;[Z01"ENOU>XM
M(YE3&7R1YYA)N$$ ;X).TVQ0''JM8#].FT O.V* /6K'P+Y[J;Q%PLT/@/"?
ML/ZT %H:R^1\+"/L$OIZ^[58/SQX3%1D\K'6:O^N%3T&8-%ZWE\O"CHHSF-U
M ;BI+]3OXN7.>D'W*<VTPN9JZWC@CXE@.&]QK;;O6GI9*TA-TB?-5MA[TQ"]
M0H&@&:HL![P\3Y.5:FN'"G3)X@*SR#K'8C".%.B18R6V=T'.K-4V/B9Z,?F]
M:[5_WQ P1:Z#,28<BX^3X2>;Y L*TB\?UXN<^KF,@7AP-'4_!P-[=V?KQ<YJ
M4SAAYP SL+;FY>[NBUODUO_!R60=4MR7VB^<5ZQM#CZ9+M_72?N^P&QCV_#@
MRQ1_UN-;&BH/L6TXOG649K W_WJ[(WIO?WVU5ESB49'![9+05V[4$[SB]")O
MWI(N?@#D;[>WQ:E2TR(6'](";9,LW.I3*V.Q]VJKGT6B'>6SK;[,9_)"A878
M.&V>W*9RY0>\!%CW>9X"Q*[#_Y9H-4^;\!_>^RTPM5Z+ER]JFOM>FKMMW>2J
M%32&MR'(B@B5:#=_7;,.W&T9QTJ\V!;](A/H67N]_:JQ7B!V]+_!!'LE.CJ'
M'8PN9+!F /XC*G(U58$X2D'S2#40^EK!=_27GW;W]MXC*K:; AC2J]V7M3?_
MNYD05WNNU?9='P%3Z7DF0Q$VTR9:ANE%= OOQ8_@0=F%2KY(\?H6@O$!P*"-
M$;NO=G>W74GO6NW3XT@6K-/2[CTM;>UP:\4,V):7KIT+PO'<L@+V-%=L<*TV
MOK_S4OPC38'YX]BU* OBU6[>/XHLQ<X6Y3Z]VGV[?1O+:.4TX!/ERX<@REO1
M!'6862OA<!U]F,8O:P7OR[UM\8DB .*DR8EW^UETL5[QL\Y7&OU]VA)BY^W>
MBYVMG9T7K^\/PDK^_MLGDKW_;41<+6?>WGT#4"3I!7=5^BQ7VW3HERCA^?+'
M;2%VW[S<?K'U^M7.'3AS!:EVWUBTBX![)?F[K=WM&L]^!'AO=_>8J_5D%&>I
MQ(&EF5+Y:O627Y3,$C4#;.N(5V_>O'BY]7)G]TV-;'?2/M.1.(C3+ KE&N#=
M2\S5.\4\*(-OQS0=?K6-U?(FML92F1X6&:BA!X=B;^_U]EL0I]M_Z$#PVG.Q
MO1>OQ4E,LVP9G59KQ@ &J9GHCZD[U6F+BTG$SNO7+[:W=H#C/B)<>OI.AAJ
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MWI60^3E%6A<2D^XA.OSVMO"^?=!@=0U.#4X-SD/DI7PG.'>88K;R7*D:@!J
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M^>*/?%@L/S!@1S]C2">,*$*VP8T6Q:62&=V4XQ_J:Z"F<(0@':X6#W%LV3L
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M!&9&M ];W:-;*%]S+9_?5--2?B\TR/G9?6R<4T+R%"F@:A528,6P?F/4E:B
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M, @B/#<\L&]DI7!:@%^FE#Q08/'0X@85[%&A<F]22"P67[.RC2M6HJAPKWD
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MTQ!P#*,$MC,+;\L&.D)0304E*=_$32'"]C9UJ$PZ$)R9=N^R#&0Z2W)]IT&
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MZL6C3+WPB[NM-\(%!$QMFE&+&E[IB)>)#Y8G")*8O#*E/58MC!''P)?2T&7
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M+?+=/Q@,P&C, ')1$!69=^EA!JP1$C 3#0X>=2V=B!K:*AO0AEN.IHQ(7#9
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MX-$?H1L4ZEJI,C?KMY"3+FLY^%3LW%*O6\>:AM@[LI#!?5XOEU/T?-/>CUP
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M]C4D_>*PGT*ON9]/89M*&=#36BSDKT]7_HIA3:*C./M15H%>:7B?>$:%L-4
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M!%;[KKZ+'F1<322//B)E..=R;=[>LQ] M6T;(3EZC:LS.I^XK$-#:34T6)\
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M0<O74AR+'V7UMV,9#[&^2>-R72@2#!>K*PF)JZ)F/)7PE545;H\Y*B8Y[*#
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MB=G0U>&BG?16X_*]%L,$QB@EJ&A(A5\++@DJ_!3%8FP$6#L3$ )SV]7GQEF
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MC=.PFQ&O>QW?]$HB5),WJN5)VE"OI%;_00/F>@/>/$WI6EUTZ(H0-[19BC.
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M<?!YF6%?"O8 @=2I T+-$;4A.& G2.'1^&P^S@(_P"EX]U-,Q<XFO#B16JR
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M2B6Z81 %QKM?&)"5U':!%Y.ZS<(Z@:U[!4E8A]=$O_@;.X5>'/@E<9Y-:/Y
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M?:BO!Z/JO026@:!I.A#B($"KFV5"W0KEQ"/6Q9ZULPP'6#JIUY+D* HJ9SB
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M"F8)OP:N\Z3ZR-ZKY_D-G<61Q_P2:<@Q?0OK-G+UJ+VU#%NFR_W^.+%6AQ;
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M.N00DK),[R ",?8@%)R3;:$HL)V@%C'=JL,V(&]+O)2C'M,J.D'(<Y/0I81
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MRH_RG]$NWOT'4$L! A0#%     @ _8DP4$)+S_C:A0  \-X# !H
M     ( !     &5X:#$P,65X>&]N<W5P<&QY86=R964N:'1M4$L! A0#%
M  @ _8DP4'6X@UU:1   ZT4  !(              ( !$H8  &9O<FTX:S Q
M,3 R,#(P+FIP9U!+ 0(4 Q0    ( /V),%#R]+:ZFQH  .7K   :
M      "  9S*  !F;W)M.&ME>'AO;G-U<'!L>6%G<F5E+FAT;5!+ 0(4 Q0
M   ( /V),%#'G_07R ,  (T3   0              "  6_E  !W<W0M,C R
M,# Q,3 N>'-D4$L! A0#%     @ _8DP4'^PZ]1& 0  _ (  !0
M     ( !9>D  '=S="TR,#(P,#$Q,%]C86PN>&UL4$L! A0#%     @ _8DP
M4,#:-JRJ 0  3@8  !0              ( !W>H  '=S="TR,#(P,#$Q,%]D
M968N>&UL4$L! A0#%     @ _8DP4&0!UZ3="0  '6@  !0
M ( !N>P  '=S="TR,#(P,#$Q,%]L86(N>&UL4$L! A0#%     @ _8DP4,HE
M$^)<!@  H#<  !0              ( !R/8  '=S="TR,#(P,#$Q,%]P<F4N
9>&UL4$L%!@     (  @ %@(  %;]      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
